All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells

Journal of Controlled Release

Volumn 149, Issue 3, 2011, Pages 281-291

  Li, Ruo Jing ^a   Ying, Xue ^a   Zhang, Yan ^a   Ju, Rui Jun ^a   Wang, Xiao Xing ^a   Yao, Hong Juan ^a   Men, Ying ^a   Tian, Wei ^a   Yu, Yang ^a   Zhang, Liang ^a   Huang, Ren Jie ^a   Lu, Wan Liang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

All trans retinoic acid stealth liposomes; Breast cancer stem cells; Cancer relapse model; Cell cycle arrest; Differentiation

Indexed keywords

BREAST CANCER STEM CELLS; CANCER RELAPSE MODEL; CELL-CYCLE ARREST; DIFFERENTIATION; STEALTH LIPOSOMES;

CHEMOTHERAPY; CYTOLOGY; ENCAPSULATION; LIPOSOMES; PHOSPHOLIPIDS; STEM CELLS; TUMORS;

DISEASES;

CD24 ANTIGEN; HERMES ANTIGEN; LIPOSOME; NAVELBINE; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RELAPSE; CANCER RESISTANCE; CANCER STEM CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENCAPSULATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MOUSE; NONHUMAN; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL CYCLE; FEMALE; HUMANS; LIPOSOMES; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; RECURRENCE; TRETINOIN; VINBLASTINE;

EID: 79951950284     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.10.019     Document Type: Article

References (49)

1. A. Hadnagy, L. Gaboury, R. Beaulieu, D. Balicki, SP analysis may be used to identify cancer stem cell populations, Exp. Cell Res. 312 (2006) 3701-3710.
2. D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M.A. Pierotti, M.G. Daidone, Isolation and in vitro propagation of tumorigenic breast cancer cellswith stem/progenitor cell properties, Cancer Res. 65 (2005) 5506-5511. (Pubitemid 40911148)
3. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, M.F. Wu, S.G. Hilsenbeck, A. Pavlick, X. Zhang, G.C. Chamness, H. Wong, J. Rosen, J.C. Chang, Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy, J. Natl Cancer Inst. 100 (2008) 672-679.
4. T.M. Phillips, W.H. McBride, F. Pajonk, The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation, J. Natl Cancer Inst. 98 (2006) 1777-1785. (Pubitemid 46017929)
5. W.A. Woodward, M.S. Chen, F. Behbod, J.M. Rosen, On mammary stem cells, J. Cell Sci. 118 (2005) 3585-3594. (Pubitemid 41309406)
6. J. Marx, Cancer research. Mutant stem cells may seed cancer, Science 301 (2003) 1308-1310. (Pubitemid 37075789)
7. C.A. Huff, W. Matsui, B.D. Smith, R.J. Jones, The paradox of response and survival in cancer therapeutics, Blood 107 (2006) 431-434. (Pubitemid 43076361)
8. A. Soltysova, V. Altanerova, C. Altaner, Cancer stem cells, Neoplasma 52 (2005) 435-440. (Pubitemid 41809399)
9. J.M. Grichnik, J.A. Burch, R.D. Schulteis, S. Shan, J. Liu, T.L. Darrow, C.E. Vervaert, H.F. Seigler, Melanoma, a tumor based on a mutant stem cell, J. Invest. Dermatol. 126 (2006) 142-153. (Pubitemid 43336106)
10. N. Haraguchi, T. Utsunomiya, H. Inoue, F. Tanaka, K. Mimori, G.F. Barnard, M. Mori, Characterization of a side population of cancer cells from human gastrointestinal system, Stem Cells 24 (2006) 506-513. (Pubitemid 44464754)
11. F.D. Camargo, S.M. Chambers, E. Drew, K.M. McNagny, M.A. Goodell, Hematopoietic stem cells do not engraft with absolute efficiencies, Blood 107 (2006) 501-507.
12. M.T. Epping, L. Wang, M.J. Edel, L. Carlee, M. Hernandez, R. Bernards, The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling, Cell 122 (2005) 835-847. (Pubitemid 41345202)
13. T. Kogai, Y. Kanamoto, L.H. Che, K. Taki, F. Moatamed, J.J. Schultz, G.A. Brent, Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models, Cancer Res. 64 (2004) 415-422. (Pubitemid 38114126)
14. S.J. Lim, J.C. Paeng, S.J. Kim, S.Y. Kim, H. Lee, D.H. Moon, Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment, J. Nucl. Med. 48 (2007) 398-404.
15. P. Montesinos, J.M. Bergua, E. Vellenga, C. Rayon, R. Parody, J. de la Serna, A. Leon, J. Esteve, G. Milone, G. Deben, C. Rivas, M. Gonzalez, M. Tormo, J. Diaz-Mediavilla, J.D. Gonzalez, S. Negri, E. Amutio, S. Brunet, B. Lowenberg, M.A. Sanz, Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors, Blood 113 (2009) 775-783.
16. S.Y. Sun, P. Yue, L. Mao, M.I. Dawson, B. Shroot, W.W. Lamph, R.A. Heyman, R.A. Chandraratna, K. Shudo, W.K. Hong, R. Lotan, Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells, Clin. Cancer Res. 6 (2000) 1563-1573.
17. J. Abu, M. Batuwangala, K. Herbert, P. Symonds, Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer, Lancet Oncol. 6 (2005) 712-720. (Pubitemid 41222762)
18. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (1986) 6387-6392. (Pubitemid 17221789)
19. R. Suzuki, T. Takizawa, Y. Kuwata, M. Mutoh, N. Ishiguro, N. Utoguchi, A. Shinohara, M. Eriguchi, H. Yanagie, K. Maruyama, Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome, Int. J. Pharm. 346 (2008) 143-150.
20. Y. Liu, W.L. Lu, J. Guo, J. Du, T. Li, J.W. Wu, G.L. Wang, J.C. Wang, X. Zhang, Q. Zhang, A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes, J. Control. Release 129 (2008) 18-25.
21. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, Q. Zhang, Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release 141 (2010) 183-192.
22. S.K. Lai, K. Hida, S.T. Man, C. Chen, C. Machamer, T.A. Schroer, J. Hanes, Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a nonclathrin, non-degradative pathway, Biomaterials 28 (2007) 2876-2884. (Pubitemid 46482662)
23. H.Y. Nam, S.M. Kwon, H. Chung, S.Y. Lee, S.H. Kwon, H. Jeon, Y. Kim, J.H. Park, J. Kim, S. Her, Y.K. Oh, I.C. Kwon, K. Kim, S.Y. Jeong, Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles, J. Control. Release 135 (2009) 259-267.
24. J.E. Schnitzer, P. Oh, E. Pinney, J. Allard, Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules, J. Cell Biol. 127 (1994) 1217-1232. (Pubitemid 24362558)
25. K.G. Rothberg, J.E. Heuser, W.C. Donzell, Y.S. Ying, J.R. Glenney, R.G. Anderson, Caveolin, a protein component of caveolaemembrane coats, Cell 68 (1992) 673-682.
26. A. Sofer, A.H. Futerman, Cationic amphiphilic drugs inhibit the internalization of cholera toxin to the Golgi apparatus and the subsequent elevation of cyclic AMP, J. Biol. Chem. 270 (1995) 12117-12122.
27. E.P. Kilsdonk, P.G. Yancey, G.W. Stoudt, F.W. Bangerter, W.J. Johnson, M.C. Phillips, G.H. Rothblat, Cellular cholesterol efflux mediated by cyclodextrins, J. Biol. Chem. 270 (1995) 17250-17256.
28. C. Hirschmann-Jax, A.E. Foster, G.G. Wulf, J.G. Nuchtern, T.W. Jax, U. Gobel, M.A. Goodell, M.K. Brenner, A distinct "side population" of cells with high drug efflux capacity in human tumor cells, Proc. Natl Acad. Sci. USA 101 (2004) 14228-14233.
29. J. Zhou, J. Wulfkuhle, H. Zhang, P. Gu, Y. Yang, J. Deng, J.B. Margolick, L.A. Liotta, E. Petricoin III, Y. Zhang, Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance, Proc. Natl Acad. Sci. USA 104 (2007) 16158-16163. (Pubitemid 350099378)
30. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc. Natl Acad. Sci. USA 100 (2003) 3983-3988. (Pubitemid 36418143)
31. M.G. Cardenas, V.C. Blank, M. Marder, L.P. Roguin, 2′-Nitroflavone induces cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells, Cancer Lett. 268 (2008) 146-157.
32. Y. Yang, J. Wang, X. Zhang, W. Lu, Q. Zhang, A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel, J. Control. Release 135 (2009) 175-182.
33. C. Mamot, D.C. Drummond, C.O. Noble, V. Kallab, Z. Guo, K. Hong, D.B. Kirpotin, J.W. Park, Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo, Cancer Res. 65 (2005) 11631-11638. (Pubitemid 41821723)
34. G.A. Challen, M.H. Little, A side order of stem cells: the SP phenotype, Stem Cells 24 (2006) 3-12.
35. J.A. Menendez, S. Ropero, M.M. del Barbacid, S. Montero, M. Solanas, E. Escrich, H. Cortes-Funes, R. Colomer, Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells, Breast Cancer Res. Treat. 72 (2002) 203-219.
36. J. Muindi, S.R. Frankel, W.H. Miller Jr., A. Jakubowski, D.A. Scheinberg, C.W. Young, E. Dmitrovsky, R.P. Warrell Jr., Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia, Blood 79 (1992) 299-303.
37. S.K. Huang, K.D. Lee, K. Hong, D.S. Friend, D. Papahadjopoulos, Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice, Cancer Res. 52 (1992) 5135-5143.
38. D.L. Daleke, K. Hong, D. Papahadjopoulos, Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay, Biochim. Biophys. Acta 1024 (1990) 352-366. (Pubitemid 20182822)
39. G.W. Liang, W.L. Lu, J.W. Wu, J.H. Zhao, H.Y. Hong, C. Long, T. Li, Y.T. Zhang, H. Zhang, J.C. Wang, X. Zhang, Q. Zhang, Enhanced therapeutic effects on the multidrug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine, Fundam. Clin. Pharmacol. 22 (2008) 429-437.
40. X. Li, W.L. Lu, G.W. Liang, G.R. Ruan, H.Y. Hong, C. Long, Y.T. Zhang, Y. Liu, J.C. Wang, X. Zhang, Q. Zhang, Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice, Eur. J. Clin. Invest. 36 (2006) 409-418. (Pubitemid 43742699)
41. X. Wang, T. Ishida, H. Kiwada, Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes, J. Control. Release 119 (2007) 236-244. (Pubitemid 46759557)
42. T. Ishida, M. Harada, X.Y. Wang, M. Ichihara, K. Irimura, H. Kiwada, Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes, J. Control. Release 105 (2005) 305-317. (Pubitemid 40941995)
43. T. Ishida, M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, E. Majima, H. Kiwada, Injection of PEGylated liposomes in rats elicits PEG-specific IgM,which is responsible for rapid elimination of a second dose of PEGylated liposomes, J. Control. Release 112 (2006) 15-25.
44. C. Kuperwasser, T. Chavarria, M. Wu, G. Magrane, J.W. Gray, L. Carey, A. Richardson, R.A. Weinberg, Reconstruction of functionally normal and malignant human breast tissues in mice, Proc. Natl Acad. Sci. USA 101 (2004) 4966-4971. (Pubitemid 38469186)
45. R. Lopez de Cicco, D.E. Bassi, S. Zucker, N.G. Seidah, A.J. Klein-Szanto, Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin, Cancer Res. 65 (2005) 4162-4171. (Pubitemid 40775654)
46. T.K. Hong, Y.C. Lee-Kim, Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells, Nutr. Res. Pract. 3 (2009) 77-83.
47. Y. Liu, M.O. Lee, H.G. Wang, Y. Li, Y. Hashimoto, M. Klaus, J.C. Reed, X. Zhang, Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells, Mol. Cell. Biol. 16 (1996) 1138-1149. (Pubitemid 26061685)
48. L.J. Donato, J.H. Suh, N. Noy, Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling, Cancer Res. 67 (2007) 609-615. (Pubitemid 46192199)
49. M. Al-Hajj, M.F. Clarke, Self-renewal and solid tumor stem cells, Oncogene 23 (2004) 7274-7282. (Pubitemid 39382161)